HSDT is trading at approximately $1.50 (8% down) in thin pre-market action with no clear catalyst yet to explain the move.

  • There are currently no fresh company-specific headlines, regulatory filings, or analyst actions tied to Helius Medical Technologies that account for the decline.
  • The price action suggests the drop may be noise in an illiquid pre-market tape rather than a clear news-driven reaction.
  • The stock previously closed at $1.63 on June 22, 2026.